Distinguished in Familial Prostate Cancer

Dr. William M. Wisbeck

Radiation Oncology
1717 13th Street, Suite 200, 
Everett, WA 
Accepting New Patients
Offers Telehealth
Distinguished in Familial Prostate Cancer
1717 13th Street, Suite 200, 
Everett, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

William Wisbeck is a Radiation Oncologist in Everett, Washington. Dr. Wisbeck is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET). Dr. Wisbeck is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Hospital Affiliations
Providence Regional Medical Center Everett
Skagit Valley Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Group Health Cooperative
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

1717 13th Street, Suite 200, Everett, WA 98201

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

GRECO-1: Phase I/II, Randomized, Placebo-Controlled Study of Stereotactic Body Radiation Therapy (SBRT) and GC4711 for Centrally Located or Large, Node-Negative Non-Small Cell Lung Cancer (NSCLC)
GRECO-1: Phase I/II, Randomized, Placebo-Controlled Study of Stereotactic Body Radiation Therapy (SBRT) and GC4711 for Centrally Located or Large, Node-Negative Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: April 30, 2024
Intervention Type: Drug
Study Drug: GC4711
Study Phase: Phase 1/Phase 2
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
Enrollment Status: Completed
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drug: GC4419
Study Phase: Phase 3
A Phase 2a Open-Label Trial of the Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis in Subjects Receiving Chemoradiotherapy for Lung Cancer
A Phase 2a Open-Label Trial of the Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis in Subjects Receiving Chemoradiotherapy for Lung Cancer
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug
Study Drug: GC4419
Study Phase: Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
Enrollment Status: Completed
Publish Date: September 20, 2021
Intervention Type: Radiation, Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

1 Total Publications

Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck.
Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck.
Journal: Cancer
Published: May 31, 2014
Similar Doctors
Distinguished in Familial Prostate Cancer
Dr. Robert M. Meier
Radiation Oncology
Distinguished in Familial Prostate Cancer
Dr. Robert M. Meier
Radiation Oncology
550 17th Avenue, Suite A10, 
Seattle, WA 
 (27.6 miles away)
206-320-7130
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Robert Meier is a Radiation Oncologist in Seattle, Washington. Dr. Meier is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Muscle Invasive Bladder Cancer. Dr. Meier is currently accepting new patients.

Richard (. Hsi
Distinguished in Familial Prostate Cancer
Dr. Richard (. Hsi
Radiation Oncology
Distinguished in Familial Prostate Cancer
Dr. Richard (. Hsi
Radiation Oncology

Seattle Cancer Care Alliance Peninsula

19917 7th Ave., Suite 100, 
Poulsbo, WA 
 (25.9 miles away)
360-697-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Richard Hsi is a Radiation Oncologist in Poulsbo, Washington. Dr. Hsi is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Squamous Cell Skin Carcinoma, and Muscle Invasive Bladder Cancer. Dr. Hsi is currently accepting new patients.

Distinguished in Familial Prostate Cancer
Dr. Steve M. Eulau
Radiation Oncology
Distinguished in Familial Prostate Cancer
Dr. Steve M. Eulau
Radiation Oncology

Tumor Institute Radiation Oncology Group Llp

1221 Madison St, Suite 1, 
Seattle, WA 
 (27.6 miles away)
209-386-2323
Languages Spoken:
English, Castilian, French, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Steve Eulau is a Radiation Oncologist in Seattle, Washington. Dr. Eulau is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and Lung Cancer. Dr. Eulau is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wisbeck's expertise for a condition
ConditionClose
    View All 33 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile